# OnCo record paper-martinez-cibrian-br-j-haematol (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-martinez-cibrian-br-j-haematol/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-martinez-cibrian-br-j-haematol" ;
  schema:name "The academic point-of-care anti-CD19 chimeric antigen receptor T-cell product varnimcabtagene autoleucel (ARI-0001 cells) shows efficacy and safety in the treatment of relapsed/refractory B-cell non-Hodgkin lymphoma"@en ;
  schema:description "Paper cited by one treatment page, indexed on Europe PMC as PubMed record 37905734 and published in British journal of haematology; the citing page links this DOI, which is how the record was matched."@en ;
  schema:url <https://onco.cc/key-papers/paper-martinez-cibrian-br-j-haematol/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1111/bjh.19170>, <https://pubmed.ncbi.nlm.nih.gov/37905734/>, <https://europepmc.org/article/MED/37905734> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1111/bjh.19170> ;
  schema:datePublished "2024"^^xsd:gYear ;
  schema:author "Martínez-Cibrián N, Ortiz-Maldonado V, Español-Rego M, et al." ;
  onco:related <https://onco.cc/drugs/varnimcabtagene-autoleucel/> .